News
Sarepta, gene therapy and Europe
Digest more
4don MSN
Sarepta Therapeutics laying off dozens in Ohio, won't comply with FDA request to halt therapy
After the FDA request, Cambridge, Massachusetts-based Sarepta said in a statement that it will continue to ship the therapy ...
Until Thursday, Sarepta Therapeutics led the race to prove that gene therapy could cure Duchenne muscular dystrophy, a genetic disorder that progressively weakens the muscles of children. Late ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback